2026-01-23 - Analysis Report
**Company Overview:**
Freeport-McMoRan is a leading mining company that engages in the exploration, extraction, and processing of minerals, primarily copper and gold.

**Return Rate Analysis**

* Cumulative return of the review stock (FCX): 187.32%
* Cumulative return of the comparison stock (S&P 500, VOO): 92.53%
* Divergence (max: 175.30, min: -44.10, current: 98.60, relative divergence: 65.00%)
* Difference in cumulative return on the last day: 95.20%
* The review stock has a higher cumulative return and divergence compared to S&P 500, indicating a greater return potential but with a higher level of risk.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -24.0% | 41.6% | -28.0% | 1.9 | 14.8B |
| 2017-2019  | -65.0% | 41.6% | -82.0% | 1.6 | 18.8B |
| 2018-2020  | 32.0% | 41.6% | 11.0% | 1.6 | 37.4B |
| 2019-2021  | 184.0% | 29.2% | 141.0% | 1.6 | 59.9B |
| 2020-2022  | 147.0% | 32.4% | 148.0% | 1.6 | 54.6B |
| 2021-2023  | 20.0% | 32.4% | 19.0% | 1.5 | 61.1B |
| 2022-2024  | -57.0% | 32.4% | -76.0% | 1.4 | 54.7B |
| 2023-2025  | 0.0% | 29.1% | -62.0% | 1.5 | 72.9B |

The review stock has demonstrated significant variations in CAGR and MDD across the analyzed periods, with some years showing high returns and others showing substantial declines. The average Beta value is around 1.6, indicating a relatively high level of correlation with the market.

**Recent Stock Price Fluctuations**

* Close: $58.85
* Last-market: {'price': 58.85, 'previousClose': 60.58, 'change': -2.86}
* 5-day SMA: $59.63
* 20-day SMA: $55.79
* 60-day SMA: $47.28
* Recent price fluctuations indicate a decline from the previous close, with the 5-day SMA still above the current price, suggesting a short-term bearish trend. The 20-day and 60-day SMAs are below the current price, indicating a medium to long-term bullish trend.

**RSI, PPO, and Delta_Previous_Relative_Divergence Analysis**

* Market Risk Indicator (MRI): 0.90 (High Investment Recommended)
* RSI: 71.49
* PPO: -0.13
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: High (MRI 0.90)
* Recent (20 days) relative divergence change: 5.20 (+)
* 7-day Rank change: 4 (+)
* 7-day Dynamic Expected Return change: 3.80 (+)
* Expected Return (%): 47.40%
* Given the MRI of 0.90, indicating a high level of risk, and the PPO of -0.13, the overall trend of the review stock is bearish in the short term. However, the RSI of 71.49 indicates that the stock is still in the overbought territory, and the recent changes in relative divergence and rank changes suggest a potential improvement in the stock's performance.

**Recent News & Significant Events**

* [2026-01-20] Here's How to Play Freeport-McMoRan Stock Before Q4 Earnings Release - Yahoo Finance
* [2026-01-22] FCX Earnings Beat; 2026 Copper Sales Outlook Trimmed - Investor's Business Daily
* [2026-01-22] Freeport-McMoRan Stock Falls on Earnings. Rising Copper and Gold Prices Werenâ€™t Enough. - Barron's
* [2026-01-22] FCX Q4 Earnings & Revenues Top Estimates, Sales Fall Y/Y on Lower Volumes - Yahoo Finance
* [2026-01-21] FCX vs. BHP: Which Copper Mining Giant Should You Invest in Now? - Yahoo Finance
* [2026-01-21] Insights Ahead: Freeport-McMoRan's Quarterly Earnings - Benzinga

The recent news highlights the review stock's Q4 earnings beating estimates, but the sales falling year-over-year due to lower volumes. Additionally, the article discusses the competition between FCX and BHP, with FCX potentially being a better investment opportunity.

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.76 (~Buy)
- Opinions: 20
- Target Price (avg/high/low): 57.70 / 69.00 / 25.00

The analyst consensus is bullish, with an average target price of 57.70 and a highest target price of 69.00.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-11-06 | 0.46 | 6.82 B$ |
| 2025-08-08 | 0.53 | 7.53 B$ |
| 2025-05-08 | 0.24 | 5.57 B$ |
| 2024-11-08 | 0.36 | 6.68 B$ |
| 2025-11-06 | 0.36 | 6.68 B$ |

The review stock's EPS and revenue have fluctuated over the past two years, with the most recent quarter showing a decline in revenue year-over-year.

**Financial Information = 5**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $6.97B | 30.72% |
| 2025-06-30 | $7.58B | 34.71% |
| 2025-03-31 | $5.73B | 26.29% |
| 2024-12-31 | $5.72B | 24.91% |
| 2024-09-30 | $6.79B | 31.12% |

The review stock's revenue and profit margin have fluctuated over the past two years, with the most recent quarter showing a profit margin of 30.72%.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $18.68B | 3.61% |
| 2025-06-30 | $18.21B | 4.24% |
| 2025-03-31 | $17.69B | 1.99% |
| 2024-12-31 | $17.58B | 1.56% |
| 2024-09-30 | $17.55B | 3.00% |

The review stock's equity and ROE have fluctuated over the past two years, with the most recent quarter showing an equity of $18.68B and an ROE of 3.61%.

**Comprehensive Analysis (Summary of previous items)**

Overall, the review stock (FCX) has demonstrated significant variations in performance over the past few years, with some periods showing high returns and others showing substantial declines. The recent news highlights the Q4 earnings beating estimates, but the sales falling year-over-year due to lower volumes. Additionally, the analyst consensus is bullish, with an average target price of 57.70. However, the MRI of 0.90 indicates a high level of risk, and the PPO of -0.13 suggests a short-term bearish trend. The review stock's recent price fluctuations and RSI of 71.49 also indicate a potential short-term decline.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.